DUBLIN, Sept 11, 2018 /PRNewswire/ --
The "Global Diabetic Macular Edema Treatment Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.
The Global Diabetic Macular Edema Treatment Market to grow at a CAGR of 1.45% during the period 2018-2022.
Global Diabetic Macular Edema Treatment Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market. To calculate the market size, the report considers the revenue generated by sales of therapeutics for diabetic macular edema across the globe.
One trend affecting this market is the use of new laser delivery systems. The redesign and replacement of the existing retinal delivery systems may result in better outcomes for the patients as these systems allow more precision and controlled allocation of rays.
According to the report, one driver influencing this market is the increase in R&D investments by pharmaceutical companies. There is a surge in investments for research and developments being made by the leading pharmaceutical companies for the development of new drugs for the treatment of diabetic macular edema.
Further, the report states that one challenge affecting this market is the lack of awareness. One of the most major challenges being faced by the vendors of the global diabetic macular edema market is the lack of awareness about the disease.
Key vendors
- ALLERGAN
- Alimera Sciences
- Bausch Health
- F. Hoffmann-La Roche
- Regeneron Pharmaceuticals
Key Topics Covered:
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
PART 05: MARKET SIZING 2017-2022
PART 06: FIVE FORCES ANALYSIS
PART 07: PIPELINE LANDSCAPE
PART 08: MARKET SEGMENTATION BY PRODUCT TYPE
- Comparison by product type
- Anti-VEGF
- Corticosteroid
- Others
- Market opportunity by product type
PART 09: CUSTOMER LANDSCAPE
PART 10: REGIONAL LANDSCAPE
- Geographical segmentation
- Regional comparison
- Market opportunity
PART 11: DECISION FRAMEWORK
PART 12: DRIVERS AND CHALLENGES
PART 13: MARKET TRENDS
PART 14: VENDOR LANDSCAPE
PART 15: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
For more information about this reportvisit
https://www.researchandmarkets.com/research/svfs2w/global_diabetic?w=5
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Related Links
http://www.researchandmarkets.com
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article